Friedberg states that 80 billion of California's 100 billion in new tax revenue went to public pensions, not schools.
“Not a big chunk, but I've done my part. And 80,000,000,000 of that went to increase and it was supposed to go to increasing schools and, like, health care services.”
Friedberg notes California ballot measure for 5% wealth tax on billionaires with legislative power to lower threshold.
“Well, it's it's on the ballot now in California to pass a wealth tax, and it starts as a one time 5% tax for billionaires, but it gives the legislature in California the ability to lower the threshold”
Friedberg asks how to fix agriculture so farmers can earn a living without government checks.
“Do think we have a path to fixing agriculture in this country? And how do we get farmers back on track where they can earn a living without requiring checks from the government?”
Friedberg notes Chevron doctrine overturn removes agencies' authority to impose regulatory rules without congressional mandate.
“And the Chevron doctrine basically allowed agencies vested agencies authority to make regulatory, rules that can then be imposed legally, statutorily.”
Friedberg argues private enterprises can allocate capital faster and smarter than government funding sources.
“I think it's about, you know, we we can aggregate more money through a central source, some federal grants or or what have you.”
Friedberg advocates ending qualified immunity and demilitarizing police training and equipment.
“I'm a huge fan of ending qualified immunity. I think that doesn't make any sense. I think we have to stop arming our police like their military.”
Friedberg says the US missed the boat on IgG and IgM antibody tests to know who has been infected.
“But what we really have missed the boat on, and we're still missing the boat on, is knowing who's been infected and to what extent this thing has actually spread already.”
Friedberg argues IgG/IgM tests should have been prioritized because they work like pregnancy kits, unlike expensive PCR tests.
“You should still have the PCR tests, but they're expensive and they take a long time to run and they require chemical labs and all this stuff.”
Friedberg argues remdesivir should be widely available without compassionate use filing since there's no mortality from taking it.
“Remdesivir should be broadly and widely available right now. People shouldn't have to file for compassionate use to get it.”